Small Pharma is evaluating the best way to administer N,N-dimethyltryptamine (DMT) in a therapeutic setting for the treatment of depressive disorders. DMT—the primary psychoactive compound in ...
UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland. The ...
OTTAWA, ON / ACCESSWIRE / June 3, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) and Altus Formulation Inc. ("Altus") today announced the launch of TALLC Corporation ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, announced today ...
LONDON, February 23, 2011 /PRNewswire/ -- Senior leaders from across the industry will meet at Pharma IQ's Global Pre Formulation and Formulation Summit in Amsterdam this April to discuss latest ...
CMP Pharma announced today the availability of the new alcohol-free reformulation of Norliqva® (amlodipine) Oral Solution, 1 mg/mL. The reformulation also has a new mixed berry flavor and improves upo ...
LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT: MAAT - the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies ...
SAN DIEGO, Calif. and OXFORD, England, April 30, 2013 /PRNewswire/ -- Glide Pharma ® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the ...
BOSTON & BALLERUP, Denmark--(BUSINESS WIRE)--Elektrofi, Inc., a Boston-based biotechnology company focused on drug formulation and delivery innovations, and LEO Pharma A/S, a global leader in medical ...
Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical company ...
(RTTNews) - Biohaven Pharmaceutical Holding Company Ltd. (BHVN) announced the FDA has authorized the initiation of clinical trials for oral zavegepant. Biohaven Pharma said it has achieved first in ...
At an aggregate level, brokerages expect high single‑digit to low double‑digit revenue growth, while margins and earnings are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results